PMC:7696151 / 48162-48418
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1397 | 223-231 | Species | denotes | patients | Tax:9606 |
| 1406 | 113-116 | Chemical | denotes | HCQ | MESH:D006886 |
| 1425 | 247-252 | Disease | denotes | lupus | MESH:D008180 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T313 | 6-253 | Sentence | denotes | Indeed, a 24-week randomized, double-blind placebo-controlled trial demonstrated that the discontinuing of HCQ treatment (100–400 mg/kg/day for at least six months) increased the risk of exacerbations by 2.5 times in patients with quiescent lupus. |